Thank you, John. Good afternoon, everyone. I'll start with a summary of the fiscal first quarter results and then provide guidance for fiscal Q2. Fiscal first quarter revenue was $317 million, which was close to the top end of our guidance range as unit volumes were higher than expected. Revenue was down 15% quarter-over-quarter and down 19% from a year ago due to lower volume of components shipping into the smartphone end market and, to a lesser extent, continued weakness in general market sales. Turning to gross margin. Non-GAAP gross profit in the quarter was $159.7 million, and non-GAAP gross margin was 50.4%, which is slightly above the midpoint of the guidance range we have provided. On a sequential basis, gross margin increased slightly, while on a year-over-year basis, gross margin declined by 110 basis points due to higher inventory reserves and a less favorable product mix. I'd like to provide an update on the high-performance mixed-signal product that John alluded to earlier. As we mentioned in the shareholder letter, we have removed the revenue associated with this component from our internal model. But during the quarter, we made good progress with both our customer and foundry partner on the disposition of wafers associated with this product, and we do not anticipate the disposition to have a material financial impact. I'd also like to reiterate that our customer relationship remains strong as we continue to collaborate on a range of technologies and programs and pursue opportunities for both the next generation of our existing components as well as new products. Turning to OpEx. Non-GAAP operating expenses in the quarter were $113.8 million, down $6 million sequentially. I'd note that operating expenses came in below the low end of our guidance range due to product development prioritization as well as controls on discretionary spending. Restructuring costs associated with the cost actions John referred to earlier are not expected to be material and are reflected in the Q2 fiscal '24 GAAP operating expense guidance. I'd note that we're continuing to invest in products and technologies in order to pursue opportunities to drive our long-term revenue growth. And overall, non-GAAP operating income was $45.8 million in the first quarter or 14.5% of revenue. And lastly, on the P&L, non-GAAP net income in the first quarter was $38 million, or $0.67 per share as the higher-than-expected revenue and the lower operating expense flowed through to the bottom line. Let me now turn to the balance sheet. Our balance sheet continues to remain strong, and we ended the first quarter of fiscal '24 with approximately $426 million in cash and cash equivalents. Our ending cash balance was down $91.1 million from the prior quarter as we built inventory to support seasonal product launches in the second half of the calendar year and also used cash to repurchase stock during the quarter. Specifically, cash used in operations was $39.8 million during the June quarter, which is about 13% of revenue. We continue to have no debt outstanding, and also, we have $300 million undrawn on our revolver. Now turning to inventory. As we indicated in prior quarters, we've been building inventory to support seasonal product launches in the second half of the calendar year, and fulfill our wafer purchase commitments for our long-term capacity agreement with GlobalFoundries. As a result, inventory was $301 million, up from $233.5 million sequentially, and days of inventory was approximately 175 days in Q1, up 60 days sequentially. Let me add some additional color on our GlobalFoundries agreement. While a portion of the capacity associated with this agreement was originally intended to support our new HPMS component, the agreement allows for wafer allocation flexibility within our product portfolio. As a result, these wafers are being reallocated to other products that use the same underlying 55-nanometer high-voltage process technology, including amplifiers, haptic drivers and battery and power ICs. Looking ahead, in Q2 fiscal '24, we expect inventory dollars to increase from the prior quarter. However, days of inventory are expected to decline due to seasonal product ramps. While we anticipate increased inventory levels of these other products during this fiscal year, we expect Q2 to be the high point of inventory for the remainder of the fiscal year. Turning now to cash flow. Cash used in operations was $39.8 million in the June quarter, and CapEx was roughly $12.3 million, resulting in free cash flow for the quarter of minus 16%. For the 12-month period ending in the June quarter, free cash flow margin was roughly 10%. On the share buyback front, in Q1, we utilized $38.5 million to repurchase approximately 466,000 shares of our common stock at an average price of $82.59. As of the end of Q1 fiscal '24, we had $462.6 million remaining in our share repurchase authorization. We expect to continue to return capital in the form of stock repurchases, which we believe will provide a long-term benefit to shareholders going forward. And now on to the guidance, for Q2 of fiscal '24, we expect revenue in the range of $430 million to $490 million. We expect gross margin to range from 49% to 51%. Non-GAAP operating expense is expected to be up sequentially in the range of $114 million to $120 million as higher variable compensation and product development costs is partially offset by lower employee expense. We will continue to control discretionary spending but invest strategically in product development to drive long-term growth. On the tax front, as we previously discussed, our fiscal 2024 non-GAAP effective tax rate will continue to be unfavorably impacted by capitalized R&D expense, and as expected, our foreign tax credits will be lower this year. Our fiscal 2024 non-GAAP tax rate is expected to be approximately 24% to 26%, consistent with our prior quarter's guidance. We continue to anticipate that the impact of capitalist R&D will become less unfavorable over time as additional years of R&D expenses are amortized for tax purposes. We're closely monitoring legislation recently introduced that would restore immediate tax deduction for R&D investments if passed. In closing, we had a solid Q1 fiscal '24 as we executed well to deliver these results. Going forward, we will continue to focus on the best opportunities to enable the Company to grow both revenue and profitability over the long term. And before we begin the Q&A, I'd like to note that fiscal year 2024 is a 53-week fiscal year and will include 14 weeks in the fiscal third quarter. And finally, while we understand there is intense interest related to our largest customer, in accordance with Cirrus Logic's company policy we will not discuss specifics about our business relationship. With that, let me now turn the call to Chelsea to start the Q&A session.